Commercialization: Page 15
-
PharmaVoice Team/PharmaVoice
Digital Influencers
Influencers have the power to positively change the status quo because of their authority, knowledge, position, or relationship with their audience. The global digital health market is expected to generate revenue of $884.1 billion, progressing at a 21.8% CAGR during the forecast period (2020-203...
By PharmaVoice Team • Jan. 1, 2021 -
PharmaVoice Team/PharmaVoice
Brigham Hyde, Ph.D. — Data Is Transforming The Landscape
From the rise of personalized medicine and value-based healthcare to evolving commercial strategies, the effective utilization of data is critical to solving for better patient outcomes. Brigham Hyde, Ph.D., a highly regarded speaker and thought leader on the value of data and analytics across th...
By Brigham Hyde • Jan. 1, 2021 -
PharmaVoice Team/PharmaVoice
Dan Wilmer — Putting Brands At The Center Of A Patient's World
To connect with consumers, you need to fit into their lives on their terms and empower them with information. As a digital strategist and innovator with a history of building large-scale consumer health businesses, Dan Wilmer recognizes the importance of creating strategies, products, and tools t...
By Dan Wilmer • Jan. 1, 2021 -
PharmaVoice Team/PharmaVoice
Breaking New Ground: The Prix Galien Awards 2020
At the end of October, 2020, The Galien Foundation presented its 2020 Prix Galien Awards to six products in four categories: Best Pharmaceutical Agent; Best Biotechnology Product; Best Medical Technology; and Best Digital Health Product, a new category for 2020. Created in 1970, the Prix Galien i...
By Carolyn Gretton • Jan. 1, 2021 -
PharmaVoice Team/PharmaVoice
The Health Tech Industry: Thriving at Last
2020 was a tough year all around, but the health tech industry emerges as a winner during the pandemic. PharmaVOICE started tracking innovation in health technology a couple of years ago. As part of this reporting, we have covered some interesting solutions. In 2020 alone, there was a great deal ...
By Robin Robinson • Jan. 1, 2021 -
PharmaVoice Team/PharmaVoice
Artificial Intelligence
Perelman School of Medicine and NIH to use AI in Alzheimer’s Research Trend Watch: AI Tools Benefit Oncology, Alzheimer’s and COVID-19 Space Researchers at the Perelman School of Medicine at the University of Pennsylvania are collaborating with 11 research centers to determine more precise diagno...
By PharmaVoice Team • Nov. 16, 2020 -
PharmaVoice Team/PharmaVoice
Q&A
Last Word
Six Keys to Beating the Odds and Achieving Startup Success Sharon Cunningham, Co-founder and CEO of Shorla Pharma, details the six steps she and her partner undertook to launch a successful biopharma company. PV: What was it like starting up Shorla Pharma? Cunningham: Starting your own c...
By Sharon Cunningham • Nov. 16, 2020 -
PharmaVoice Team/PharmaVoice
SHOWCASE: Supply Chain Management: The Supply Chain: Risks and Opportunities
COVID-19 caused shockwaves throughout the global supply chain of every industry. For the pharmaceutical industry, the pandemic highlighted the fragility of the supply chain and the importance of being able to adjust to demand in a changed environment. The COVID-19 pandemic has demonstrated that c...
By PharmaVoice Team • Nov. 16, 2020 -
PharmaVoice Team/PharmaVoice
Solving Today's Patient-Centric Supply Chains
Precision oncology, CAR-T cell therapy, gene therapy, CRISPR-Cas9 —scientific advances in the space of cell and gene therapy have made a significant impact on patient care. Biopharma company pipelines are developing advanced treatments at an inspiring pace. Even amid the ongoing COVID-19 pandemic...
By Joe DePinto • Nov. 16, 2020 -
PharmaVoice Team/PharmaVoice
Virtual Trials: Navigating Change and Avoiding Blinds Spots
As 2020 draws to a close, we reflect on the changes we have had to make in all facets of our lives due to the pandemic. Some were overdue and some are here to stay. Some were easy to adopt and others we resisted. Change of any sort, positive or negative, is known to be one of life’s great stresso...
By Kenneth G. Faulkner • Nov. 16, 2020 -
PharmaVoice Team/PharmaVoice
Personal Technology and Artificial Intelligence Will Provide for Better Health Outcomes
More and more, pharmaceutical companies are continuing to leverage wearable technology to not only track patient information and vitals, but also track their behavior over time. When a patient’s vitals are taken at a medical facility, only a brief window of data is recorded and monitored. With we...
By Juan Garcia • Nov. 16, 2020 -
PharmaVoice Team/PharmaVoice
Telehealth: Ready or Not — <del>Here it Comes</del>… It's Here to Stay
Our world is changing more rapidly than ever before, but certain constants remain imperative in the healthcare arena — human connection and access to education. Healthcare professionals (HCPs) need to be able to connect with their patients to properly assess their conditions. HCPs need access to ...
By Christine Molbury • Nov. 16, 2020 -
PharmaVoice Team/PharmaVoice
The Next Chapter for Real World Evidence: Validating Data with the Patient Voice
In June 2020, in accordance with the 21st Century Cures Act of 2016 and the Prescription Drug User Fee Act (PDUFA), the U.S. Food and Drug Administration (FDA) launched Project Patient Voice. This patient-focused drug development initiative facilitates systematic approaches to collecting and usin...
By Ramita Tandon • Nov. 16, 2020 -
PharmaVoice Team/PharmaVoice
COVID-19: Silver Linings
COVID-19 has stretched our industry to adjust to all types of new “normals," yet amid all of the disruption and loss of life, there are pockets of light that are expected to lift the life sciences and its people to new heights. Of all the industries that have been impacted across the globe, the l...
By Taren Grom • Nov. 16, 2020 -
PharmaVoice Team/PharmaVoice
Age of the Machine: The Expanded Role of AI in Pharma
AI and machine learning have the potential to transform the life-sciences industry, but barriers around implementation, process, and regulatory uncertainty must be overcome first. Artificial intelligence and machine learning are very much part of the pharmaceutical landscape today and are expecte...
By Kim Ribbink • Nov. 16, 2020 -
PharmaVoice Team/PharmaVoice
Breaking Glass: Driving Diversity, Equity, and Inclusion
As companies grapple with an emotional year in terms of the pandemic and racial inequality, efforts to address diversity and inclusion are gaining momentum. When Joe Biden and Kamala Harris won the 2020 U.S. presidential election, it signaled a huge leap forward for diversity: the first woman Vic...
By Kim Ribbink • Nov. 16, 2020 -
PharmaVoice Team/PharmaVoice
Commanders & Chiefs: Chief Experience Officers
Chief experience officers are influencing the strategic direction of their companies to address the needs and wants of their customers. Julie Adrian Customer Focus “Get closer than ever to your customers. So close that you tell them what they need well before they realize it themselves." This quo...
By PharmaVoice Team • Nov. 16, 2020 -
PharmaVoice Team/PharmaVoice
What Life Sciences Leaders Say During the Pandemic: 10 Key Takeaways
We are in a global pandemic that is exposing major issues in the commercial environment in which healthcare companies operate, with changes that are completely altering the landscape for the long term. Our 3rd Annual Leaders in Life Sciences Roundtable consisted of eight industry leaders with div...
By Edward John Allera • Nov. 16, 2020 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Is the industry ready for an AI revolution? We hooked into AI’s potential impact on the life-sciences industry a couple of years ago. We were early enthusiasts, but by no means the first to grasp the importance of the technology on everything from drug innovation to commercial strategies. We even...
By Taren Grom • Oct. 1, 2020 -
PharmaVoice Team/PharmaVoice
Upfront
Takeda’s Innovators in Science Award Takeda Pharmaceuticals and the New York Academy of Sciences are drawing attention to the urgent needs of patients worldwide affected by an estimated 7,000 rare diseases. The 2020 Innovators in Science Award recognizes scientists from around the globe for their...
By PharmaVoice Team • Oct. 1, 2020 -
PharmaVoice Team/PharmaVoice
HealthTech
Organ-on-a-Chip Transforms Drug Development Trend Watch: Healthtech Applications Run the Gamut from Chip Technology to EHRs, to Electronic Skin and Clinical Trials Draper’s Ex Vivo Immuno-oncology Dynamic Environment for Tumor biopsies (EVIDENT) is a microfluidic platform that maintains tumor fra...
By PharmaVoice Team • Oct. 1, 2020 -
PharmaVoice Team/PharmaVoice
Artificial Intelligence
BenevolentAI Validates Baricitinib as Treatment for COVID-19 Trend Watch: AI solutions span counseling, selfies, biopsies and drug discovery London-based BenevolentAI has reported that data released from a large scale randomized clinical trial, sponsored by the National Institute of Allergy and ...
By PharmaVoice Team • Oct. 1, 2020 -
PharmaVoice Team/PharmaVoice
Creative Executions
Creative thinking inspires ideas. Ideas inspire change. — Barbara Januszkiewicz In the new-ish omnichannel world of advertising that includes print, TV, social media, etc., great creative based on great ideas, good data, and a fearless approach to ideation is the lynchpin that leads to great camp...
By Taren Grom • Oct. 1, 2020 -
PharmaVoice Team/PharmaVoice
Commercial Influencers
Influencers have the power to positively change the status quo because of their authority, knowledge, position, or relationship with their audience. According to the global consultancy Evaluate, the impact of COVID-19 has so far wiped $7.85 billion off forecasts for biopharma sales in 2020, with ...
By PharmaVoice Team • Oct. 1, 2020 -
PharmaVoice Team/PharmaVoice
Roshawn Blunt — Optimizing a Strategic Plan
Given cell and gene therapies are typically personalized medicines, they come with outlier pricing and other unique commercialization challenges that differ from other large and small molecule therapies. Roshawn Blunt, a respected biotech consultant, was inspired by President John Adams, who in 1...
By Roshawn Blunt • Oct. 1, 2020
Previous
